Clever Fruit Products (Clever), which produces fermented superfruit natural ingredients, has recently closed its 1st traunch of its preseed round.

The close was a full half the preseed’s round target of $1m and the company has commitments for the remainder of the round. The company also continues to attract non-dilutative funding which now totals over $1.2m.

“Our capital needs remain modest, driven by our success with non-dilutative funding programs, as we finish our pre-launch science program.”, said Sean Sears, Chief Executive Officer for Clever. “We are grateful for all the investor and non-dilutive research funding we have leveraged to drive Clever forward.  “That said, using metabolite structure to modulate microbiome and target specific health outcomes has so many opportunities their will be no end to continuous scientific discovery. We are still just getting started. ”

Clever is a developer of fermented natural health ingredients for functional foods (beverages), supplements, and nutraceutical brands. Its mission is to enhance the health of society using fermentation to increase the potency of antioxidant-rich superfruit. Clever’s products modulate the microbiome aiding the body’s gut, brain, skin and cell health. It works to bring the microbiome back into balance by helping to  limit the health damaging effects of inflammation and oxidative stress.

Media contact:

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.